Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 25 June, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of TTK Healthcare Ltd

Basic Stock Data

Last Updated: June 25, 2024, 10:16 pm

Market Cap 2,083 Cr.
Current Price 1,475
High / Low1,744/1,101
Stock P/E33.2
Book Value 708
Dividend Yield0.68 %
ROCE8.67 %
ROE6.43 %
Face Value 10.0
PEG Ratio0.86

Competitors of TTK Healthcare Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Anuh Pharma Ltd 1,122 Cr. 224265/97.118.7 58.10.89 %29.4 %22.6 % 5.00
Zota Health Care Ltd 1,381 Cr. 534555/336 34.80.19 %7.32 %16.8 % 10.0
Procter & Gamble Health Ltd 8,275 Cr. 4,9855,643/4,63738.6 4851.87 %45.5 %33.5 % 10.0
Ajanta Pharma Ltd 29,316 Cr. 2,3312,540/1,37836.3 2831.54 %31.6 %23.2 % 2.00
Ipca Laboratories Ltd 27,958 Cr. 1,1021,375/72947.3 2500.36 %13.2 %9.70 % 1.00
Industry Average15,490.25 Cr1,215.3338.45189.940.35%17.42%16.83%6.46

Quarterly Result

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Sales139131150159159193170183180202186184181
Expenses129125148150154189166174165192176179169
Operating Profit106385448151010512
OPM %7%5%2%5%3%2%2%5%8%5%5%3%7%
Other Income7515101260613121215161616
Interest0001131111101
Depreciation3333333333333
Profit before tax12814141260413162321221824
Tax %17%22%7%15%13%1%23%26%27%24%26%27%25%
Net Profit10613121160110121716161318
EPS in Rs7.324.259.078.617.52425.237.018.4911.9911.0911.339.1212.93

Last Updated: June 9, 2024, 5:51 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 25, 2024, 8:57 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Sales382416483519528578628646476599725753
Expenses362396453478489535578617457577694715
Operating Profit202030403843502819223137
OPM %5%5%6%8%7%7%8%4%4%4%4%5%
Other Income76766889284264363
Interest334335332353
Depreciation33671215151413131313
Profit before tax2220263629303919324865784
Tax %34%37%39%36%36%40%38%37%-44%13%3%25%
Net Profit1412162319182412464264063
EPS in Rs18.2815.9520.8129.1924.1312.8617.258.7232.8729.43452.7244.47
Dividend Payout %22%25%22%17%21%39%29%34%18%34%2%22%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-14.29%33.33%43.75%-17.39%-5.26%33.33%-50.00%283.33%-8.70%1423.81%-90.16%
Change in YoY Net Profit Growth (%)0.00%47.62%10.42%-61.14%12.13%38.60%-83.33%333.33%-292.03%1432.51%-1513.97%

Growth

Compounded Sales Growth
10 Years:6%
5 Years:4%
3 Years:17%
TTM:4%
Compounded Profit Growth
10 Years:18%
5 Years:21%
3 Years:16%
TTM:-90%
Stock Price CAGR
10 Years:8%
5 Years:19%
3 Years:32%
1 Year:17%
Return on Equity
10 Years:27%
5 Years:32%
3 Years:38%
Last Year:6%

Last Updated: June 21, 2024, 4:49 pm

Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital88888814141414141414
Reserves809099110128150219237235281316939958
Borrowings18223242382347293019222725
Other Liabilities8689102115128104127136152180207189185
Total Liabilities1922092402753032854074164314945591,1701,182
Fixed Assets3343545210699110988985807177
CWIP60246101290032
Investments7100109913913151314
Other Assets1461651841771851772883043253954631,0831,090
Total Assets1922092402753032854074164314945591,1701,182

Reserves and Borrowings Chart

TTK Healthcare Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 624133937182517209645-26
Cash from Investing Activity -4-1-15-49-275-2210-13-77-3033
Cash from Financing Activity -1-223-11-23-7-31-10-17-10-12
Net Cash Flow1220-7-00-4-4-425-6

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-2.00-12.00-12.002.0015.00-4.0021.00-2.000.000.004.0014.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days343434332435474346334642
Inventory Days5264626665807710112310289105
Days Payable55565053100130101121170134131110
Cash Conversion Cycle31414646-11-162223-21436
Working Capital Days-8-12-14-22-9-11013-18-151762
ROCE %21%17%20%23%18%15%15%8%6%8%10%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters74.56%74.56%74.56%74.56%74.56%74.57%74.57%74.57%74.57%74.57%74.57%74.57%
FIIs2.04%2.32%2.35%2.40%2.34%2.37%2.32%2.38%2.40%1.85%1.85%1.85%
DIIs2.29%2.26%2.23%2.40%2.51%2.22%2.18%2.99%3.27%3.23%3.13%1.14%
Public21.11%20.86%20.85%20.64%20.59%20.84%20.95%20.07%19.76%20.37%20.46%22.45%
No. of Shareholders15,97417,11516,41615,81715,22814,61714,99515,81816,10915,67216,65117,221

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Axis ELSS Tax Saver Fund172,3860.0825.52172,3862024-06-200%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)44.47452.7229.4332.878.72
Diluted EPS (Rs.)44.47452.7229.4332.878.72
Cash EPS (Rs.)53.71461.7938.3442.0818.89
Book Value[Excl.RevalReserv]/Share (Rs.)708.35671.59230.16205.40173.09
Book Value[Incl.RevalReserv]/Share (Rs.)708.35674.71233.28208.52176.21
Dividend / Share (Rs.)10.0010.0010.006.003.00
Revenue From Operations / Share (Rs.)532.75513.16424.08336.91457.01
PBDIT / Share (Rs.)70.7256.3927.0120.7026.23
PBIT / Share (Rs.)61.4847.3318.1111.4916.06
PBT / Share (Rs.)59.5343.6217.5816.0113.75
Net Profit / Share (Rs.)44.47452.7229.4332.878.72
PBDIT Margin (%)13.2710.986.366.145.74
PBIT Margin (%)11.549.224.263.413.51
PBT Margin (%)11.178.504.144.753.00
Net Profit Margin (%)8.3488.226.949.751.90
Return on Networth / Equity (%)6.2767.4112.7816.005.03
Return on Capital Employeed (%)8.646.977.565.318.73
Return On Assets (%)5.2354.677.449.392.85
Total Debt / Equity (X)0.020.020.060.060.11
Asset Turnover Ratio (%)0.630.831.141.031.52
Current Ratio (X)5.505.062.031.991.74
Quick Ratio (X)5.014.661.681.611.32
Inventory Turnover Ratio (X)1.912.231.921.381.64
Dividend Payout Ratio (NP) (%)0.002.2020.389.1257.34
Dividend Payout Ratio (CP) (%)0.002.1615.657.1226.46
Earning Retention Ratio (%)0.0097.8079.6290.8842.66
Cash Earning Retention Ratio (%)0.0097.8484.3592.8873.54
Interest Coverage Ratio (X)36.2715.2111.7917.1011.34
Interest Coverage Ratio (Post Tax) (X)23.819.535.9517.774.77
Enterprise Value (Cr.)1342.13639.44918.42488.79358.06
EV / Net Operating Revenue (X)1.780.881.531.030.55
EV / EBITDA (X)13.438.0324.0616.719.66
MarketCap / Net Operating Revenue (X)2.782.011.961.470.71
Retention Ratios (%)0.0097.7979.6190.8742.65
Price / BV (X)2.091.543.602.411.89
Price / Net Operating Revenue (X)2.782.011.961.470.71
EarningsYield0.020.430.030.060.02

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value: 1,521.69

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 3.17% compared to the current price 1475

Intrinsic Value: 2,107.83

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 42.90% compared to the current price ₹1475

Last 5 Year EPS CAGR: 38.52%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of 0.25, which is a positive sign.
  2. The company has higher reserves (315.92 cr) compared to borrowings (29.50 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (561.08 cr) and profit (86.83 cr) over the years.
  1. The stock has a low average ROCE of 13.42%, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 18.42, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in TTK Healthcare Ltd:
    1. Net Profit Margin: 8.34%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 8.64% (Industry Average ROCE: %)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 6.27% (Industry Average ROE: %)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 23.81
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 5.01
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. ✗ Stock P/E: 33.2 (Industry average Stock P/E: )
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.02
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company

TTK Healthcare Ltd. is a Public Limited Listed company incorporated on 21/05/1958 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1958PLC003647 and registration number is 003647. Currently Company is involved in the business activities of Manufacture of other rubber products. Company’s Total Operating Revenue is Rs. 599.24 Cr. and Equity Capital is Rs. 14.13 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsNo 6, Cathedral Road, Chennai (Madras) Tamil Nadu 600086info@ttkhealthcare.com
http://www.ttkhealthcare.com
Management
NamePosition Held
Mr. T T RaghunathanExecutive Chairman
Mr. S KalyanaramanWhole Time Director
Mr. R K TulshanDirector
Mr. K ShankaranDirector
Dr.(Mrs.) Vandana R WalvekarDirector
Mr. Girish RaoDirector
Mr. S BalasubramanianDirector
Mr. N Ramesh RajanDirector
Mr. V RanganathanDirector
Dr. T T MukundDirector

FAQ

What is the latest fair value of TTK Healthcare Ltd?

The latest fair value of TTK Healthcare Ltd is ₹1521.69.

What is the Market Cap of TTK Healthcare Ltd?

The Market Cap of TTK Healthcare Ltd is 2,083 Cr..

What is the current Stock Price of TTK Healthcare Ltd as on 25 June 2024?

The current stock price of TTK Healthcare Ltd as on 25 June 2024 is ₹1,475.

What is the High / Low of TTK Healthcare Ltd stocks in FY 2024?

In FY 2024, the High / Low of TTK Healthcare Ltd stocks is 1,744/1,101.

What is the Stock P/E of TTK Healthcare Ltd?

The Stock P/E of TTK Healthcare Ltd is 33.2.

What is the Book Value of TTK Healthcare Ltd?

The Book Value of TTK Healthcare Ltd is 708.

What is the Dividend Yield of TTK Healthcare Ltd?

The Dividend Yield of TTK Healthcare Ltd is 0.68 %.

What is the ROCE of TTK Healthcare Ltd?

The ROCE of TTK Healthcare Ltd is 8.67 %.

What is the ROE of TTK Healthcare Ltd?

The ROE of TTK Healthcare Ltd is 6.43 %.

What is the Face Value of TTK Healthcare Ltd?

The Face Value of TTK Healthcare Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in TTK Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE